Selection and characterization of small molecules that bind the HIV-1 frameshift site RNA

ACS Chemical Biology

Volumn 4, Issue 10, 2009, Pages 844-854

  Marcheschi, Ryan J ^a   Mouzakis, Kathryn D ^a   Butcher, Samuel E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYLCAINE; CINCHONIDINE; DOXORUBICIN; IDARUBICIN; VIRUS RNA;

ARTICLE; DRUG BINDING; HIGH THROUGHPUT SCREENING; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RIBOSOMAL FRAMESHIFTING; RNA REPLICATION; RNA STRUCTURE; RNA TRANSLATION; VIRUS REPLICATION;

BASE SEQUENCE; BINDING SITES; DOXORUBICIN; FRAMESHIFTING, RIBOSOMAL; HIV INFECTIONS; HIV-1; HUMANS; MODELS, MOLECULAR; NUCLEIC ACID CONFORMATION; RNA, VIRAL; SMALL MOLECULE LIBRARIES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70350167221     PISSN: 15548929     EISSN: None     Source Type: Journal    
DOI: 10.1021/cb900167m     Document Type: Article

References (47)

1. Lefebvre, E., and Schiffer, C. A. (2008) Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir, AIDS Rev. 10, (3), 131-142.
2. Schiller, D. S., and Youssef-Bessler, M. (2009) Etravirine: a second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIV, Clin. Ther. 31, (4), 692-704.
3. Dinman, J. D., Ruiz-Echevarria, M. J., and Peltz, S. W. (1998) Translating old drugs into new treatments: ribosomal frameshifting as a target for antiviral agents, Trends Biotechnol. 16, (4), 190-196. (Pubitemid 128712952)
4. Hung, M., Patel, P., Davis, S., and Green, S. R. (1998) Importance of ribosomal frameshifting for human immunodeficiency virus type 1 particle assembly and replication, J. Virol. 72, (6), 4819-4824. (Pubitemid 28215658)
5. McNaughton, B. R., Gareiss, P. C., and Miller, B. L. (2007) Identification of a selective small-molecule ligand for HIV-1 frameshift-inducing stem-loop RNA from an 11,325 member resin bound dynamic combinatorial library, J. Am. Chem. Soc. 129, (37), 11306-11307.
6. Staple, D. W., Venditti, V., Niccolai, N., Elson-Schwab, L., Tor, Y., and Butcher, S. E. (2008) Guanidinoneomycin B recognition of an HIV-1 RNA helix, ChemBioChem 9, (1), 93-102.
7. Horiya, S., Koh, C. S., Matsufuji, S., and Harada, K. (2008) Analysis of the interaction between selected RNA-binding peptides and a target RNA containing a bulge and a GNRA-type tetraloop, Nucleic Acids Symp. Ser. (52), 209-210.
8. Dulude, D., Theberge-Julien, G., Brakier-Gingras, L., and Heveker, N. (2008) Selection of peptides interfering with a ribosomal frameshift in the human immunodeficiency virus type 1, RNA 14, (5), 981-991. (Pubitemid 351574919)
9. Jacks, T., Power, M. D., Masiarz, F. R., Luciw, P. A., Barr, P. J., and Varmus, H. E. (1988) Characterization of ribosomal frameshifting in HIV-1 gag-pol expression, Nature 331, (6153), 280-283. (Pubitemid 18040598)
10. Parkin, N. T., Chamorro, M., and Varmus, H. E. (1992) Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on downstream mRNA secondary structure: demonstration by expression in vivo, J. Virol. 66, (8), 5147-5151.
11. Park, J., and Morrow, C. D. (1991) Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production, J. Virol. 65, (9), 5111-5117.
12. Kim, Y. G., Maas, S., and Rich, A. (2001) Comparative mutational analysis of cis-acting RNA signals for translational frameshifting in HIV-1 and HTLV-2, Nucleic Acids Res. 29, (5), 1125-1131. (Pubitemid 32186198)
13. Leger, M., Sidani, S., and Brakier-Gingras, L. (2004) A reassessment of the response of the bacterial ribosome to the frameshift stimulatory signal of the human immunodeficiency virus type 1, RNA 10, (8), 1225-1235. (Pubitemid 38989008)
14. Dulude, D., Baril, M., and Brakier-Gingras, L. (2002) Characterization of the frameshift stimulatory signal controlling a programmed -1 ribosomal frameshift in the human immunodeficiency virus type 1, Nucleic Acids Res. 30, (23), 5094-5102. (Pubitemid 36033026)
15. Dulude, D., Berchiche, Y. A., Gendron, K., Brakier-Gingras, L., and Heveker, N. (2006) Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1, Virology 345, (1), 127-136. (Pubitemid 43107578)
16. Shehu-Xhilaga, M., Crowe, S. M., and Mak, J. (2001) Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity, J. Virol. 75, (4), 1834-1841. (Pubitemid 32110173)
17. Brierley, I., and Pennell, S. (2001) Structure and function of the stimulatory RNAs involved in programmed eukaryotic-1 ribosomal frameshifting, Cold Spring Harbor Symp. Quant. Biol. 66, 233-248. (Pubitemid 36097930)
18. Telenti, A., Martinez, R., Munoz, M., Bleiber, G., Greub, G., Sanglard, D., and Peters, S. (2002) Analysis of natural variants of the human immunodeficiency virus type 1 gag-pol frameshift stem-loop structure, J. Virol. 76, (15), 7868-7873. (Pubitemid 34761010)
19. Bidou, L., Stahl, G., Grima, B., Liu, H., Cassan, M., and Rousset, J. P. (1997) In vivo HIV-1 frameshifting efficiency is directly related to the stability of the stem-loop stimulatory signal, RNA 3, (10), 1153-1158. (Pubitemid 27424282)
20. Gaudin, C., Mazauric, M. H., Traikia, M., Guittet, E., Yoshizawa, S., and Fourmy, D. (2005) Structure of the RNA signal essential for translational frameshifting in HIV-1, J. Mol. Biol. 349, (5), 1024-1035. (Pubitemid 40779623)
21. Yusupova, G. Z., Yusupov, M. M., Cate, J. H., and Noller, H. F. (2001) The path of messenger RNA through the ribosome, Cell 106, (2), 233-241.
22. Baril, M., Dulude, D., Gendron, K., Lemay, G., and Brakier-Gingras, L. (2003) Efficiency of a programmed -1 ribosomal frameshift in the different subtypes of the human immunodeficiency virus type 1 group M, RNA 9, (10), 1246-1253. (Pubitemid 37151678)
23. Staple, D. W., and Butcher, S. E. (2003) Solution structure of the HIV-1 frameshift inducing stem-loop RNA, Nucleic Acids Res. 31, (15), 4326-4331. (Pubitemid 37441793)
24. Staple, D. W., and Butcher, S. E. (2005) Solution structure and thermodynamic investigation of the HIV-1 frameshift inducing element, J. Mol. Biol. 349, (5), 1011-1023.
25. Kirk, S. R., Luedtke, N. W., and Tor, Y. (2001) 2-Aminopurine as a real-time probe of enzymatic cleavage and inhibition of hammerhead ribozymes, Bioorg. Med. Chem. 9, (9), 2295-2301.
26. Holmen, A., Norden, B., and Albinsson, B. (1997) Electronic transition moments of 2-aminopurine, J. Am. Chem. Soc. 119, (13), 3114-3121.
27. Xu, D., Evans, K. O., and Nordlund, T. M. (1994) Melting and premelting transitions of an oligomer measured by DNA base fluorescence and absorption, Biochemistry 33, (32), 9592-9599. (Pubitemid 24272917)
28. Ward, D. C., Reich, E., and Stryer, L. (1969) Fluorescence studies of nucleotides and polynucleotides. I. Formycin, 2-aminopurine riboside, 2,6-diaminopurine riboside, and their derivatives, J. Biol. Chem. 244, (5), 1228-1237.
29. Menger, M., Tuschl, T., Eckstein, F., and Porschke, D. (1996) Mg(2+)-dependent conformational changes in the hammerhead ribozyme, Biochemistry 35, (47), 14710-14716. (Pubitemid 26423802)
30. Lacourciere, K. A., Stivers, J. T., and Marino, J. P. (2000) Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy, Biochemistry 39, (19), 5630-5641.
31. Dalvit, C., Pevarello, P., Tato, M., Veronesi, M., Vulpetti, A., and Sundstrom, M. (2000) Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water, J. Biomol. NMR 18, (1), 65-68. (Pubitemid 30782901)
32. Dalvit, C., Fogliatto, G., Stewart, A., Veronesi, M., and Stockman, B. (2001) WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability, J. Biomol.NMR21, (4), 349-359. (Pubitemid 34071389)
33. Johnson, E. C., Feher, V. A., Peng, J. W., Moore, J. M., and Williamson, J. R. (2003) Application of NMR SHAPES screening to an RNA target, J. Am. Chem. Soc. 125, (51), 15724-15725.
34. Grentzmann, G., Ingram, J. A., Kelly, P. J., Gestaland, R. F., and Atkins, J. F. (1998) A dual-luciferase reporter system for studying recoding signals, RNA 4, (04), 479-486. (Pubitemid 28160788)
35. Dinman, J. D., Ruiz-Echevarria, M. J., Czaplinski, K., and Peltz, S. W. (1997) Peptidyl-transferase inhibitors have antiviral properties by altering programmed -1 ribosomal frameshifting efficiencies: development of model systems, Proc. Natl. Acad. Sci. U.S.A. 94, (13), 6606-6611. (Pubitemid 27281911)
36. Arcamone, F. (1981) Doxorubicin: Anticancer Antibiotics, Vol.17, Academic Press, New York, NY.
37. Gabizon, A., Shmeeda, H., and Barenholz, Y. (2003) Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies, Clin. Pharmacokinet. 42, (5), 419-436. (Pubitemid 36649037)
38. Momparler, R. L., Karon, M., Siegel, S. E., Avila, F., and Effect of adriamycin on DNA, R. N. A. (1976) and protein synthesis in cell-free systems and intact cells, Cancer Res. 36, (8), 2891-2895.
39. Fornari, F. A., Randolph, J. K., Yalowich, J. C., Ritke, M. K., and Gewirtz, D. A. (1994) Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells, Mol. Pharmacol. 45, (4), 649-656. (Pubitemid 24139191)
40. Frederick, C. A., Williams, L. D., Ughetto, G., van der Marel, G. A., van Boom, J. H., Rich, A., and Wang, A. H. (1990) Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin, Biochemistry 29, (10), 2538-2549. (Pubitemid 20100850)
41. Chaires, J. B., Satyanarayana, S., Suh, D., Fokt, I., Przewloka, T., and Priebe, W. (1996) Parsing the free energy of anthracycline antibiotic binding to DNA, Biochemistry 35, (7), 2047-2053. (Pubitemid 26075442)
42. Canzoneri, J. C., and Oyelere, A. K. (2008) Interaction of anthracyclines with iron responsive element mRNAs, Nucleic Acids Res. 36, (21), 6825-6834.
43. Bergamini, A., Perno, C. F., Balzarini, J., Capozzi, M., Marinelli, L., Milanese, G., Pesce, C. D., Calio, R., and Rocchi, G. (1992) Selective inhibition of HIV replication by adriamycin in macrophages but not in lymphocytes, AIDS Res. Hum. Retroviruses 8, (7), 1239-1247.
44. Marcheschi, R. J., Staple, D. W., and Butcher, S. E. (2007) Programmed ribosomal frameshifting in SIV is induced by a highly structured RNA stem-loop, J. Mol. Biol. 373, (3), 652-663.
45. Bindslev, N. (2008) Drug-Acceptor Interactions: Modeling Theoretical Tools To Test and Evaluate Experimental Equilibrium Effects, p 428, Co-Action Publishing, Sweden.
46. John, D. M., and Weeks, K. M. (2000) van't Hoff enthalpies without baselines, Protein Sci. 9, (07), 1416-1419.
47. Piotto, M., Saudek, V., and Sklenar, V. (1992) Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions, J. Biomol. NMR 2, (6), 661-665.